Total submissions: 14
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000177733 | SCV000229653 | likely benign | not specified | 2015-04-15 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001701540 | SCV000243103 | benign | not provided | 2021-02-23 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 29741288, 31515523) |
Genetic Services Laboratory, |
RCV000177733 | SCV000249025 | likely benign | not specified | 2021-02-09 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000547579 | SCV000633778 | likely benign | Early infantile epileptic encephalopathy with suppression bursts | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002317038 | SCV000850651 | likely benign | Inborn genetic diseases | 2023-05-24 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Institute of Human Genetics, |
RCV000601636 | SCV001440756 | likely benign | Developmental and epileptic encephalopathy, 5 | 2019-01-01 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000601636 | SCV002056585 | benign | Developmental and epileptic encephalopathy, 5 | 2021-07-15 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000601636 | SCV002804506 | likely benign | Developmental and epileptic encephalopathy, 5 | 2022-02-09 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001701540 | SCV004156417 | benign | not provided | 2024-08-01 | criteria provided, single submitter | clinical testing | SPTAN1: BP4, BS1, BS2 |
Bioinformatics Core, |
RCV000656025 | SCV000588301 | pathogenic | Childhood epilepsy with centrotemporal spikes | 2017-01-01 | flagged submission | case-control | CAADphred>15 |
Diagnostic Laboratory, |
RCV000601636 | SCV000734648 | likely benign | Developmental and epileptic encephalopathy, 5 | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV001701540 | SCV001932112 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
OMIM | RCV001701540 | SCV004037432 | uncertain significance | not provided | 2023-09-29 | no assertion criteria provided | literature only | |
Prevention |
RCV004552997 | SCV004766944 | likely benign | SPTAN1-related disorder | 2020-01-31 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |